Serum CA15-3 levels were observed to have a proportional correlation with the progress of breast cancer, but they exhibited a less correlation with the progress of breast cancer (P < 0.05, from one-way ANOVA analysis) compared with Trx1 (P < 0.0001). This evidence concerns the gene TXN and breast cancer.